ARCHIVES

NTP Board Considers Modification Of Human Risk Statement, Adopts Plan For Chemical Selection

This article is from The Cancer Letter archive.

Vol. 06 No. 44 | November 7, 1980

Download PDF Visit The Full Archive

Related Articles

High-Dose Vitamin D With Docetaxel In Testing For Advanced Prostate Cancer

September 27, 2002

Conversations With The Cancer Letter: Youle: ACS Stance on Tobacco Sales Is Clear

April 18, 2014

In Brief: Hohn Named President, CEO Of Roswell Park; Mendelsohn Honored; AACE Elects Officers

February 7, 1997

SPOREs In Breast, Prostate Cancers Win $12.7 Million.

October 6, 2000

Columbus CCP Forms New Entity to Administer CCOP

July 20, 1990

Three Experimental Beamlines To Be Built For Research.

May 17, 2002